FACS analysis demonstrates that approximately 90% of TcdBFBD-bound cells from primary p53/BRCA1-deficient tumors were FZD7+ (S13A Fig), confirming that TcdBFBD targeted FZD7+ cells in tumor tissues. Here, TP53 is linked to neoplasm.